Downregulation of semaphorin 3E promotes hallmarks of experimental chronic allergic asthma
View/ Open
Author
Movassagh, Hesam
Shan, Lianyu
Chakir, Jamila
Halayko, Andrew J.
Koussih, Latifa
Gounni, Abdelilah S.
Published Version
https://doi.org/10.18632/oncotarget.22144Metadata
Show full item recordCitation
Movassagh, Hesam, Lianyu Shan, Jonathan S. Duke-Cohan, Jamila Chakir, Andrew J. Halayko, Latifa Koussih, and Abdelilah S. Gounni. 2017. “Downregulation of semaphorin 3E promotes hallmarks of experimental chronic allergic asthma.” Oncotarget 8 (58): 98953-98963. doi:10.18632/oncotarget.22144. http://dx.doi.org/10.18632/oncotarget.22144.Abstract
Guidance cues such as semaphorins are attractive novel therapeutic targets for allergic disorders. We have previously described an inhibitory effect of semaphorin 3E (Sema3E) on human airway smooth muscle cell function. We have further addressed a canonical role for Sema3E in acute model of allergic asthma in vivo. Considering the chronic nature of the disease, the potential implication of Sema3E to alleviate long-lasting deficits should be investigated. Expression of Sema3E in a chronic model of allergic asthma was assessed after exposure to house dust mite (HDM) as a clinically relevant allergen. Chronic features of allergic asthma including airway hyper-responsiveness (AHR), inflammation, and remodeling were studied in Sema3E-deficient mice. Additionally, the effect of exogenous Sema3E treatment was evaluated in prophylactic and therapeutic experimental models. We have demonstrated that expression of Sema3E is robustly suppressed in the airways upon chronic HDM exposure. Chronic allergic airway disease was significantly augmented in Sema3E-deficient mouse model which was associated with an increased AHR, remodeling, and Th2/Th17 inflammation. Intranasal Sema3E administration restored chronic deficits of allergic asthma in mice. Data from this study unveil a key regulatory role of Sema3E in chronic course of asthma via orchestration of impaired inflammatory and remodeling responses.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716780/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:34651815
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)